VILDA 50 MG

VILDA is indicated for adjuvant treatment with diet and physical activity in patients with type 2 diabetes: -As monotherapy when diet and physical activity are not sufficient In double combination: – with metformin when diet , physical activity and metformin alone do not provide sufficient blood sugar control – with a sulfonylurea when diet, physical activity, and the sulfonylurea do not provide sufficient blood sugar control – with a thiazolidinedione when diet, physical activity and thiazolidinedione do not provide them with sufficient blood sugar control In triple combination: – with metformin and a sulfonylurea when diet, physical activity and the double combination of these two substances do not provide sufficient blood sugar control. Galvus is also indicated in combination with insulin (with or without metfomine) when diet, physical activity and a stable dose of insulin do not provide sufficient blood sugar control.